Contraindications to use of metformin

BMJ

Volumn 326, Issue 7392, 2003, Pages 762-

  Elder, Andrew T ^a   Hague, W M ^b   Davoren, P M ^c   Oliver, J ^d   Rowan, j ^e   Jones, Philip ^f   Yate, Paul ^f   Macklin, J P ^g   Alexander, W D ^a   Jones, G C ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

^e National Women's Hospital   (South Africa)

^f BARTS HEALTH NHS TRUST   (United Kingdom)

^g GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CREATININE; INSULIN; IODINATED CONTRAST MEDIUM; LACTIC ACID; METFORMIN; PROTEIN;

AGE; CLINICAL TRIAL; CREATININE CLEARANCE; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG SAFETY; HUMAN; HYPOXEMIA; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY FUNCTION; LACTIC ACIDOSIS; LETTER; MUSCLE MASS; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN METABOLISM;

EID: 0037420491     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.326.7392.762/a     Document Type: Letter

References (15)

1. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ 2003; 326: 4–5
2. Chehade JM, Mooradian AD. Drug therapy: current and emerging agents. In: Sinclair AJ, Finucane P,eds. Diabetes in old age. Chichester: Wiley, 2001: 202–203
3. Hendra TJ, Sinclair AJ. Improving the care of elderly diabetic patients; the final report of the St Vincent Joint Task Force for Diabetes. Age Ageing 1997; 26: 3–6
4. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31
5. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ 2003; 326: 4–5
6. Coetzee E, Jackson W. The management of non-insulin-dependent diabetes during pregnancy. Diab Res Clin Pract 1986; 1: 281–287
7. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 520–525
8. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diab Med 2000; 17: 507–511
9. Barker D. Mothers, babies and health in later life. Edinburgh: Churchill Livingstone, 1998.
10. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ 2003; 326: 4–5
11. UKPDS Study Group. Effect of Intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 43). Lancet 1998; 352: 854–865
12. Lalau JD, Vermesh A, Hary L, Andrajek M, Isnard F, Quichaud J. Type 2 diabetes in the elderly: an assessment of metformin use in type 2 diabetes. Int Clin Pharmacol Ther Toxicol 1990; 28: 329–332
13. Scottish Intercollegiate Guidelines Network. SIGN 55: Management of diabetes. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, Royal College of Physicians, 2001.
14. National Institute for Clinical Excellence. Management of type 2 diabetes—renal disease, prevention and early management. London: NICE, 2002. http://www.nice.org.uk/article.asp?a=27964 (accessed 21 Mar 2003).
15. Deray G, Bellin MF, Boulchfar H, Baumelou B, Koskas F, Baumelou A, et al. Nephrotoxicity of contrast media in high risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents. Am J Nephrol 1991; 11: 309–312